FDAFDA · Food and drugs·Recall number D-0649-2017
RIVASTIGMINE Tartrate Capsules, USP, 1.5 mg, 60-count bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally 500-900 India, NDC 55111-352-60
Published April 12, 2017 · Recall initiated: March 6, 2017
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Cross-contamination with other products -Related Substances test for Rivastigmine Tartrate Capsules USP, 1.5 mg showed a peak for Ranitidine.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- RIVASTIGMINE TARTRATE
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Distributor
- U.S. nationwide
- Lot
- Lot #C607323, Exp 10/18
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.